Medtronic

Industry / private company


Location: Minneapolis, United States (USA) (US) US

ISNI: 0000000095452456

ROR: https://ror.org/00grd1h17

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Long-Term, Patient-Level Analysis of Radiofrequency Renal Denervation in the SYMPLICITY Clinical Trial Program (2025) Mahfoud F, Townsend RR, Kandzari DE, Mancia G, Whitbourn R, Lauder L, Bhatt DL, et al. Journal article Novel approaches to define responders to interventional treatment in hypertension: insights from the SPYRAL HTN-OFF and HTN-ON MED trials (2025) Schmieder R, Hettrick DA, Böhm M, Kandzari DE, Kario K, Mahfoud F, Tsioufis K, et al. Journal article Renal Denervation Lowers Nighttime Blood Pressure in True Resistant Hypertension (2024) Kario K, Kandzari DE, Mahfoud F, Weber MA, Schmieder R, Tsioufis K, Liu M, et al. Journal article, Letter Impact of Antihypertensive Medication Changes after Renal Denervation among Different Patient Groups: SPYRAL HTN-ON MED (2024) Townsend RR, Ferdinand KC, Kandzari DE, Kario K, Mahfoud F, Weber MA, Schmieder R, et al. Journal article A novel, proof-of-concept radiofrequency renal denervation strategy to improve procedural efficiency: 12-month results from the SPYRAL DYSTAL pilot study (2024) Sharp AS, Kandzari DE, Townsend RR, Kario K, Mahfoud F, Weber MA, Schmieder R, et al. Journal article Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE (2023) Mahfoud F, Mancia G, Schmieder R, Ruilope L, Narkiewicz K, Schlaich M, Williams B, et al. Journal article LONG-TERM REDUCTION IN MORNING AND NIGHTTIME BLOOD PRESSURE AFTER RENAL DENERVATION: 36-MONTH RESULTS FROM SPYRAL HTN-ON MED PILOT TRIAL (2023) Kario K, Mahfoud F, Kandzari DE, Townsend RR, Weber MA, Schmieder R, Tsioufis K, et al. Conference contribution Effect of Radiofrequency Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs: 6-Month Primary Results From the SPYRAL HTN-ON Med Expansion Randomized Trial (2022) Kandzari DE, Townsend RR, Kario K, Mahfoud F, Weber MA, Schmieder R, Pocock S, et al. Conference contribution Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure Range (2022) Mahfoud F, Mancia G, Schmieder R, Ruilope L, Narkiewicz K, Schlaich M, Williams B, et al. Journal article Blood pressure reduction in higher cardiovascular risk patients in the Global SYMPLICITY Registry (2022) Rodriguez O, Mahfoud F, Schmieder R, Schlaich M, Narkiewicz K, Ruilope L, Williams B, et al. Journal article